JP2023025108A5 - - Google Patents

Download PDF

Info

Publication number
JP2023025108A5
JP2023025108A5 JP2022188263A JP2022188263A JP2023025108A5 JP 2023025108 A5 JP2023025108 A5 JP 2023025108A5 JP 2022188263 A JP2022188263 A JP 2022188263A JP 2022188263 A JP2022188263 A JP 2022188263A JP 2023025108 A5 JP2023025108 A5 JP 2023025108A5
Authority
JP
Japan
Prior art keywords
seq
acid sequence
amino acid
ile
trp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022188263A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023025108A (ja
JP7461445B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2016/050875 external-priority patent/WO2017048593A1/en
Application filed filed Critical
Publication of JP2023025108A publication Critical patent/JP2023025108A/ja
Publication of JP2023025108A5 publication Critical patent/JP2023025108A5/ja
Application granted granted Critical
Publication of JP7461445B2 publication Critical patent/JP7461445B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022188263A 2015-09-15 2022-11-25 Hla-cw8拘束性の変異krasを認識するt細胞受容体 Active JP7461445B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562218688P 2015-09-15 2015-09-15
US62/218,688 2015-09-15
PCT/US2016/050875 WO2017048593A1 (en) 2015-09-15 2016-09-09 T cell receptors recognizing hla-cw8 restricted mutated kras
JP2018513423A JP7185524B2 (ja) 2015-09-15 2016-09-09 Hla-cw8拘束性の変異krasを認識するt細胞受容体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018513423A Division JP7185524B2 (ja) 2015-09-15 2016-09-09 Hla-cw8拘束性の変異krasを認識するt細胞受容体

Publications (3)

Publication Number Publication Date
JP2023025108A JP2023025108A (ja) 2023-02-21
JP2023025108A5 true JP2023025108A5 (cg-RX-API-DMAC7.html) 2023-04-25
JP7461445B2 JP7461445B2 (ja) 2024-04-03

Family

ID=56985686

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018513423A Active JP7185524B2 (ja) 2015-09-15 2016-09-09 Hla-cw8拘束性の変異krasを認識するt細胞受容体
JP2022188263A Active JP7461445B2 (ja) 2015-09-15 2022-11-25 Hla-cw8拘束性の変異krasを認識するt細胞受容体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018513423A Active JP7185524B2 (ja) 2015-09-15 2016-09-09 Hla-cw8拘束性の変異krasを認識するt細胞受容体

Country Status (13)

Country Link
US (3) US10556940B2 (cg-RX-API-DMAC7.html)
EP (2) EP3901169B1 (cg-RX-API-DMAC7.html)
JP (2) JP7185524B2 (cg-RX-API-DMAC7.html)
KR (2) KR20250117744A (cg-RX-API-DMAC7.html)
CN (2) CN108350059B (cg-RX-API-DMAC7.html)
AU (3) AU2016323017B2 (cg-RX-API-DMAC7.html)
DK (1) DK3350213T3 (cg-RX-API-DMAC7.html)
ES (1) ES2879287T3 (cg-RX-API-DMAC7.html)
IL (1) IL257840B2 (cg-RX-API-DMAC7.html)
MX (1) MX2018003062A (cg-RX-API-DMAC7.html)
SA (1) SA518391109B1 (cg-RX-API-DMAC7.html)
SG (1) SG10201913868XA (cg-RX-API-DMAC7.html)
WO (1) WO2017048593A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4339287A3 (en) 2015-07-31 2024-05-22 Regents Of The University Of Minnesota Modified cells and methods of therapy
SG11201900654QA (en) * 2016-08-02 2019-02-27 Us Health Anti-kras-g12d t cell receptors
GB201700621D0 (en) 2017-01-13 2017-03-01 Guest Ryan Dominic Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue
EP3602053B1 (en) * 2017-03-31 2023-06-28 The United States of America, as represented by The Secretary, Department of Health and Human Services Methods of isolating neoantigen-specific t cell receptor sequences
US11807662B2 (en) 2017-05-16 2023-11-07 The Johns Hopkins University MANAbodies and methods of using
CN111511375A (zh) 2017-06-30 2020-08-07 因提玛生物科学公司 用于基因治疗的腺相关病毒载体
AU2018335274B2 (en) * 2017-09-20 2025-02-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services HLA class II–restricted T cell receptors against mutated RAS
US12227554B2 (en) 2017-10-05 2025-02-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for selectively expanding cells expressing a TCR with a murine constant region
MX2020005765A (es) 2017-12-04 2020-09-25 Us Health Receptores de celulas t restringidos a antigeno leucocitario humano (hla) clase i contra sarcoma de rata (ras) mutado.
SG11202012653XA (en) * 2018-06-19 2021-01-28 Biontech Us Inc Neoantigens and uses thereof
AU2019321608B2 (en) 2018-08-16 2024-07-25 Biontech Us Inc. T cell receptor constructs and uses thereof
WO2020154275A1 (en) * 2019-01-22 2020-07-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hla class ii-restricted t cell receptors against ras with g12r mutation
GB2613715B (en) 2019-02-20 2023-12-06 Fred Hutchinson Cancer Center Binding proteins specific for RAS neoantigens and uses thereof
US20220175899A1 (en) * 2019-04-11 2022-06-09 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic t lymphocytes specific for mutated forms of epidermal growth factor receptor for use in treating cancer
CN110172089B (zh) * 2019-06-11 2020-01-07 北京鼎成肽源生物技术有限公司 一种kras突变多抗原组合、靶向kras突变肿瘤ctl及其应用
CN112110995A (zh) * 2019-06-19 2020-12-22 上海交通大学医学院 肿瘤新抗原多肽及其用途
EP4016437A4 (en) * 2019-08-14 2022-08-17 NEC Corporation INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD AND RECORDING MEDIUM
CN112759641B (zh) * 2019-11-01 2023-01-20 香雪生命科学技术(广东)有限公司 一种识别Kras G12V的高亲和力TCR
WO2021127184A1 (en) 2019-12-17 2021-06-24 The Johns Hopkins University MANAbodies TARGETING TUMOR ANTIGENS AND METHODS OF USING
JP2023507432A (ja) 2019-12-20 2023-02-22 インスティル バイオ (ユーケイ) リミテッド 腫瘍浸潤リンパ球を単離するためのデバイスおよび方法ならびにそれらの使用
MX2022009825A (es) * 2020-02-14 2022-10-13 Us Health Receptores de células t restringidas por hla de la clase i contra ras con mutación g12v.
US20230159614A1 (en) * 2020-02-26 2023-05-25 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Hla class ii-restricted t cell receptors against ras with g12v mutation
CN111574616B (zh) * 2020-06-17 2021-02-02 深圳豪石生物科技有限公司 分离的t细胞受体和应用
WO2022015922A1 (en) * 2020-07-16 2022-01-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hla class ii-restricted drb t cell receptors against ras with g12v mutation
AU2021351710A1 (en) * 2020-10-02 2023-06-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hla class ii-restricted dq t cell receptors against ras with g13d mutation
JP2024507929A (ja) 2021-02-25 2024-02-21 アラウノス セラピューティクス インコーポレイテッド 多シストロン性発現カセットを含む組換えベクター及びそれらの使用方法
WO2023150562A1 (en) 2022-02-01 2023-08-10 Alaunos Therapeutics, Inc. Methods for activation and expansion of t cells
CN114920824B (zh) * 2022-05-27 2023-12-05 重庆医科大学 Tcr或其抗原结合片段及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7301017B2 (en) * 2002-05-30 2007-11-27 Kolesnick Richard N Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
US8034334B2 (en) 2002-09-06 2011-10-11 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
HUE038833T2 (hu) * 2005-08-05 2018-11-28 Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh Antigénspecifikus T-sejtek létrehozása
US8383099B2 (en) 2009-08-28 2013-02-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adoptive cell therapy with young T cells
ES2635335T3 (es) * 2010-09-20 2017-10-03 Biontech Cell & Gene Therapies Gmbh Receptores de células T específicos de antígeno y epítopos de células T
US20120244133A1 (en) 2011-03-22 2012-09-27 The United States of America, as represented by the Secretary, Department of Health and Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
SI2755997T1 (sl) * 2011-09-15 2018-11-30 The United States of America, as represented by Secretary, Department of Health and Human Services, Office of Technology Transfer, National Institutes of Health T-celični receptorji, ki prepoznajo HLA-A1- ali HLA-CW7-omejeni mage
GB201314404D0 (en) * 2013-08-12 2013-09-25 Immunocore Ltd T Cell Receptors
SG10201913978RA (en) * 2014-11-26 2020-03-30 The United States Of America As Represented By The Secretary Anti-mutated kras t cell receptors

Similar Documents

Publication Publication Date Title
JP2022050400A5 (cg-RX-API-DMAC7.html)
CN112300269B (zh) Kras突变特异性t细胞受体筛选及抗肿瘤用途
TWI801862B (zh) 抗tigit的抗體、其製備方法和應用
Clark et al. Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domains.
EP3271387B1 (en) Trispecific binding molecules for treating hbv infection and associated conditions
Sukhatme et al. The T cell differentiation antigen Leu-2/T8 is homologous to immunoglobulin and T cell receptor variable regions
JP2021191265A5 (cg-RX-API-DMAC7.html)
JP6397886B2 (ja) 治療用ペプチド
JP2021520198A5 (cg-RX-API-DMAC7.html)
CN106029694A (zh) 治疗性肽
Chrétien et al. CTX, a novel molecule specifically expressed on the surface of cortical thymocytes in Xenopus
KR20210121141A (ko) Cd3-특이적 결합 분자
CN103097414B (zh) 膜联蛋白1抗体
JP7735285B2 (ja) G12v突然変異rasに対するhlaクラスi拘束性t細胞受容体
JP2025063321A5 (cg-RX-API-DMAC7.html)
US5601822A (en) γ, δ T cell receptor and methods for detection
WO2021216468A1 (en) Human tigit specific single domain antibodies and methods of use
JP2018535647A5 (cg-RX-API-DMAC7.html)
JP2022523696A (ja) Car細胞上の非天然nkg2d受容体に、結合した異種分子を選択的に送達する改変非天然nkg2dリガンド
Henwood et al. Restricted T cell receptor expression by human T cell clones specific for mycobacterial 65‐kDa heat‐shock protein: selective in vivo expansion of T cells bearing defined receptors
JPH08501925A (ja) 糖蛋白pに対するモノクローナル抗体
Bjorkman et al. Model for the interaction of T-cell receptors with peptide/MHC complexes
JP2022523024A5 (cg-RX-API-DMAC7.html)
WO2019192493A1 (zh) 抗人lag-3单克隆抗体及其应用
Polakova et al. Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity